GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PsyBio Therapeutics Corp (OTCPK:PSYBF) » Definitions » Total Receivables

PsyBio Therapeutics (PsyBio Therapeutics) Total Receivables : $0.00 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PsyBio Therapeutics Total Receivables?

PsyBio Therapeutics's Total Receivables for the quarter that ended in Jun. 2023 was $0.00 Mil.


PsyBio Therapeutics Total Receivables Historical Data

The historical data trend for PsyBio Therapeutics's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PsyBio Therapeutics Total Receivables Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
Total Receivables
- -

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PsyBio Therapeutics Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


PsyBio Therapeutics Total Receivables Related Terms

Thank you for viewing the detailed overview of PsyBio Therapeutics's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


PsyBio Therapeutics (PsyBio Therapeutics) Business Description

Traded in Other Exchanges
Address
4400 Sample Road, Suite 138, Coconut Creek, FL, USA, 33073
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

PsyBio Therapeutics (PsyBio Therapeutics) Headlines